Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

128.00 +1.36 (+1.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,240,115
Open 133.00
Bid (Size) 127.25 (1)
Ask (Size) 130.20 (5)
Prev. Close 126.64
Today's Range 127.24 - 135.43
52wk Range 110.03 - 219.44
Shares Outstanding 145,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biogen Earnings: What To Look For From BIIB
Biotech company Biogen (NASDAQ:BIIB) will be reporting results this Thursday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
From Biogen Inc.
Via GlobeNewswire

Performance

YTD
-14.7%
-14.7%
1 Month
-1.6%
-1.6%
3 Month
+5.8%
+5.8%
6 Month
-12.5%
-12.5%
1 Year
-40.0%
-40.0%

More News

Read More
1 Nasdaq 100 Stock to Target This Week and 2 That Underwhelm
Via StockStory
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
Via Benzinga
Topics Economy
Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate
Via Benzinga
Biogen (NASDAQ:BIIB) Reports Bullish Q2
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For July 31, 2025
Via Benzinga
Biogen's Earnings Outlook
Via Benzinga
Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
From Biogen Inc.
Via GlobeNewswire
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
Via Benzinga
Topics Government
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
Via Benzinga
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
From Biogen Inc.
Via GlobeNewswire
Biogen (BIIB) Stock Trades Down, Here Is Why
Via StockStory
Topics Lawsuit
Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing
Via Benzinga
What's going on in today's session: S&P500 movers
Via Chartmill
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park in Conjunction with its 30th Anniversary
From Biogen Inc.
Via GlobeNewswire
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
Via StockStory
Topics Lawsuit
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
Via Benzinga
3 Low-Volatility Stocks in Hot Water
Via StockStory
Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
From Stoke Therapeutics, Inc.
Via Business Wire
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
From Biogen Inc.
Via GlobeNewswire
What's Driving the Market Sentiment Around Biogen?
Via Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
Via Stocktwits
1 Value Stock with Exciting Potential and 2 to Approach with Caution
Via StockStory
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
From Biogen Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 128.00
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 07/31/25 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 18.66B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.